Page last updated: 2024-11-05

allyl carbamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID16454
SCHEMBL ID29564
SCHEMBL ID9763314
MeSH IDM0106664

Synonyms (41)

Synonym
allyl carbamate
nsc32609
2114-11-6
carbamic acid, 2-propenyl ester
carbamic acid, allyl ester
wln: zvo2u1
nsc-32609
brn 1745069
nsc 32609
hsdb 2714
nsc 63830
einecs 218-309-6
allylurethane
nsc63830
nsc-63830
prop-2-enyl carbamate
4-03-00-00062 (beilstein handbook reference)
carbamic acid, 2-propen-1-yl ester
unii-imp2j1yj2y
imp2j1yj2y ,
AKOS006222282
allylurethane [hsdb]
SCHEMBL29564
OCAAZRFBJBEVPS-UHFFFAOYSA-N
carbamic acid allyl ester
o-allyl carbamate
SCHEMBL9763314
dtxcid4030413
cas-2114-11-6
dtxsid1051856 ,
NCGC00357158-01
tox21_303906
allyl carbamate, 95%
EN300-210216
prop-2-en-1-yl carbamate
mfcd00025468
Q27280799
D97550
prop-2-en-1-ylcarbamate
AS-76151
CS-0199028

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's3 (42.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.17 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]